The genetic disease affects people's muscle movement so severely, it inhibits their ability to breathe, swallow, or walk. In fact it's so life-threatening, most infants who are diagnosed with it won't make it to the age of 2. So thank God a drug company swooped in to create a miraculous, life-saving drug that will help treat such a severe disability. This is great news, right?
Except it will cost patients a whopping $750,000 (!!!) in the first year of treatment.
That's right, three-quarters of a million dollars to save your kid's life, and that's just for the first year. Luckily, the price drops after that -- to a mere $375,000 a year for subsequent years... because anything more would just be a selfish form of price gouging.